Personal Capital Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$1.55M Buy
3,026
+81
+3% +$41.1K 0.01% 222
2022
Q3
$1.34M Buy
2,945
+1,340
+83% +$641K 0.01% 224
2022
Q2
$775K Buy
1,605
+12
+0.8% +$5.94K ﹤0.01% 248
2022
Q1
$783K Sell
1,593
-129
-7% -$59K ﹤0.01% 264
2021
Q4
$794K Buy
1,722
+231
+15% +$97.2K ﹤0.01% 280
2021
Q3
$556K Sell
1,491
-40
-3% -$15.2K ﹤0.01% 297
2021
Q2
$585K Sell
1,531
-49
-3% -$18.7K ﹤0.01% 291
2021
Q1
$567K Buy
1,580
+508
+47% +$163K ﹤0.01% 291
2020
Q4
$344K Buy
+1,072
New +$329K ﹤0.01% 356

Other funds holding ELV

Personal Capital Advisors's ELV Position: Q4 2022 in Review

Personal Capital Advisors increased its Elevance Health (ELV) stake by 2.8% in Q4 2022, buying an estimated $41.1K and bringing the position to 3,026 shares worth $1.55M. The position accounts for 0.01% of the portfolio, ranked #222.

Personal Capital Advisors first reported a position in ELV in Q4 2020 and has held it in 9 quarters since. 1,548 funds tracked by Wall St. Rank hold ELV as of Q4 2022.

  • Personal Capital Advisors held 3,026 shares of Elevance Health worth $1.55M as of Q4 2022.
  • Personal Capital Advisors bought 81 Elevance Health shares in Q4 2022, an estimated $41.1K.
  • Elevance Health made up 0.01% of Personal Capital Advisors's portfolio in Q4 2022, its #222 holding.
  • Personal Capital Advisors first reported a position in Elevance Health in Q4 2020 and has held it in 9 quarters since.
  • 1,548 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.

Based on Personal Capital Advisors's 13F filing for Q4 2022, filed 15 Feb 2023.